[1]
|
A Review of FDA-Approved Multi-Target Angiogenesis Drugs for Brain Tumor Therapy
International Journal of Molecular Sciences,
2025
DOI:10.3390/ijms26052192
|
|
|
[2]
|
Challenges and advances in glioblastoma targeted therapy: the promise of drug repurposing and biomarker exploration
Frontiers in Oncology,
2024
DOI:10.3389/fonc.2024.1441460
|
|
|
[3]
|
New Insights Into Glioblastoma
2023
DOI:10.1016/B978-0-323-99873-4.00009-8
|
|
|
[4]
|
New Insights Into Glioblastoma
2023
DOI:10.1016/B978-0-323-99873-4.00009-8
|
|
|
[5]
|
Estimation for finite mixture of simplex models: applications to biomedical data
Statistical Modelling,
2018
DOI:10.1177/1471082X17722607
|
|
|
[6]
|
Estimation for finite mixture of simplex models: applications to biomedical data
Statistical Modelling: An International Journal,
2017
DOI:10.1177/1471082X17722607
|
|
|
[7]
|
A Phase II Study of Antineoplastons A10 and AS2-1 in Patients with Brainstem Gliomas. The Report on Non-Diffuse Intrinsic Pontine Glioma (Protocol BT-11)
Journal of Cancer Therapy,
2015
DOI:10.4236/jct.2015.64036
|
|
|